Camtek Ltd (CAMT)

Camtek Ltd (CAMT) shares recently gained 3.2%, bringing its price to $146.66, significantly above its GF Value™ estimate of $118.30, indicating it is overvalued. While the company boasts a strong GF Score™ of 95/100, driven by excellent growth and momentum, its valuation and a high P/E ratio suggest caution for investors. Insider activity shows $5.1 million in sales and no purchases over the past year, contrasting with some guru investors adding to their positions.

Israel stocks closed higher on Tuesday, with the TA 35 index gaining 0.35%. Top performers included Camtek Ltd, Migdal Insurance, and Clal Insurance, while ICL Israel Chemicals Ltd, Next Vision Stabilized Systems, and NICE Ltd saw declines. Commodities like crude oil and Brent oil fell, as did Gold Futures, while the USD/ILS and EUR/ILS also dropped.

Camtek Ltd reported record Q1 2025 revenues of $119 million, a more than 20% year-over-year increase, with gross margin rising to over 52% and operating income exceeding $37 million. The company diversified its customer base and successfully launched new models, the Eagle G5 and Hawk, strengthening its competitive position in advanced packaging for AI applications. However, concerns remain regarding geopolitical issues, tariffs, and increased operating expenses, alongside competition from larger players in sub-micron defect detection and 3D metrology.

Northland Securities has increased its Q3 2026 EPS estimate for Camtek (NASDAQ:CAMT) to $0.91 from $0.82, with full-year 2026 EPS projected at $3.16. This adjustment follows Camtek's recent strong quarterly performance, where it exceeded both EPS and revenue consensus estimates. Despite a "Moderate Buy" consensus rating and positive analyst sentiment, insider selling activity totaling over $4.5 million was noted in the last quarter.

Camtek (CAMT) recently reported record Q2 revenue, driven by AI-related Advanced Packaging, and strong order intake, leading to significant share price gains. While one valuation narrative suggests Camtek is undervalued at $187.25 based on AI-driven growth, another Discounted Cash Flow model indicates the stock is overvalued at its current price of $171.80, trading well above an estimated future cash flow value of $46.65. This disparity creates mixed signals on whether the AI upside is already fully priced into the stock.